CLOVER HEALTH INVESTMENTS, CORP. /DE — Form 4
Filed September 16, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
CEO, Counterpart Health Wai Conrad (CLOV) sold 300K shares (~$1.4M) on the open market (20% of holdings). Large sale — ~20% of holdings.
Why this rating
Large sale — ~20% of holdings.
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.